We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sharfstein: J&J Phantom Recall Demonstrates Need for FDA Mandatory Recall Authority
Sharfstein: J&J Phantom Recall Demonstrates Need for FDA Mandatory Recall Authority
October 1, 2010
A senior FDA official told lawmakers that having mandatory recall authority power could have prevented Johnson & Johnson’s (J&J) so-called phantom recall of defective Motrin.